This website uses cookies. By using this website, you agree to our Cookie Policy.
November 18, 2020
Cadwalader is advising Population Health Investment Co., Inc. (Nasdaq: PHICU) on its $150 million initial public offering of 15,000,000 units at a price of $10.00 per unit. The offering was priced on November 17 and is expected to close November 20.
Population Health Investment Co., Inc. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While Population Health may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus on companies or divisions of companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. The company was founded by Dr. Clive Meanwell and Ian Read.
The Cadwalader team includes Corporate partner Greg Patti and associates Frank Bozzi and Erica Hogan and Tax partner Jason Schwartz and associate Matthew Seitz.
our latest insights on the impact of COVID-19 to help you navigate this unprecedented environment.
Patrick Quinn and Ruth Merisier discuss the legal profession, working at Cadwalader, and more.
Selections to the Lawdragon 500 are limited to no more than 500 lawyers in the country.
Our latest podcast covers the legacy of the “Car Wash” investigation and how Brazil fits into the global landscape of white-collar crime enforcement.